Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

Worldwide Patterns of Bronchodilator Responsiveness: Results From the Burden of Obstructive Lung Disease Study

Thorax

Pulmonary

Respiratory Medicine

2012

English

P2.02-043 Multicenter Assessment of PD-L1 Immunohistochemistry: Challenges for Establishing the Concordance Between Four Different Antibodies

Journal of Thoracic Oncology

English

P2.17-32 Dynamic Monitoring Before and After Neo-Adjuvant Crizotinib in Non-Small Cell Lung Cancer: A Brief Report

Journal of Thoracic Oncology

English

Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer

Journal of Thoracic Oncology

English

MA02.02 Multistate Healthcare Network Underutilizes Valuable End-Of-Life Resources in Stage IV Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P3.07-12 Improving Cardiac Tamponade Outcomes Through Less Invasive Interventions and Earlier Recognition

Journal of Thoracic Oncology

English

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

Journal of Thoracic Oncology

English

OA05.07 IMpower132: PFS and Safety Results With 1L Atezolizumab + Carboplatin/Cisplatin + Pemetrexed in Stage IV Non-Squamous NSCLC

Journal of Thoracic Oncology

English

S9 Acute Inflammatory Presentation Associates With Survival in Interstitial Lung Disease and Extracorporeal Membrane Oxygenation-Requiring Severe Respiratory Failure: A Single Centre Case Series

English

OA10.05 an Open-Label, Multicenter, Phase II Single Arm Trial of Osimertinib in NSCLC Patients With Uncommon EGFR Mutation(KCSG-Lu15-09)

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

Worldwide Patterns of Bronchodilator Responsiveness: Results From the Burden of Obstructive Lung Disease Study

P2.02-043 Multicenter Assessment of PD-L1 Immunohistochemistry: Challenges for Establishing the Concordance Between Four Different Antibodies

P2.17-32 Dynamic Monitoring Before and After Neo-Adjuvant Crizotinib in Non-Small Cell Lung Cancer: A Brief Report

Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer

MA02.02 Multistate Healthcare Network Underutilizes Valuable End-Of-Life Resources in Stage IV Non-Small Cell Lung Cancer

P3.07-12 Improving Cardiac Tamponade Outcomes Through Less Invasive Interventions and Earlier Recognition

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

OA05.07 IMpower132: PFS and Safety Results With 1L Atezolizumab + Carboplatin/Cisplatin + Pemetrexed in Stage IV Non-Squamous NSCLC

S9 Acute Inflammatory Presentation Associates With Survival in Interstitial Lung Disease and Extracorporeal Membrane Oxygenation-Requiring Severe Respiratory Failure: A Single Centre Case Series

OA10.05 an Open-Label, Multicenter, Phase II Single Arm Trial of Osimertinib in NSCLC Patients With Uncommon EGFR Mutation(KCSG-Lu15-09)